IBB: Failing Growth Narratives & Overvaluation In Biotech (NASDAQ:IBB)

Biotech stocks enjoyed strong hype and trajectories in the recent past, especially during the pandemic years. Find out why the sector isn't very attractive now.

Related Keywords

United States ,Ireland ,Canada ,United Kingdom ,Cayman Islands ,America ,American ,Sandeepg Rao , ,Bloomberg ,Exchange Traded Products Etps ,Atai Life Sciences ,Exchange Traded Funds ,Shares Biotechnology ,Invesco Dynamic Biotech ,Vaneck Biotech ,Assets Under Management ,Ark Invest ,Historical Ratio Analysis ,North American ,Switzerland Based Crispr Therapeutics ,Star Rating ,Investor Sentiment ,Price Trends ,Exchange Traded Products ,